The obesity epidemic is a significant global health issue. Improved understanding of the mechanisms that regulate appetite and body weight will provide the rationale for the design of anti-obesity therapies. Thyroid hormones play a key role in metabolic homeostasis through their interaction with thyroid hormone receptors (TRs), which function as ligandinducible transcription factors. The TR-beta isoform (TRb) is expressed in the ventromedial hypothalamus (VMH), a brain area important for control of energy homeostasis. Here, we report that selective knockdown of TRb in the VMH of adult mice results in severe obesity due to hyperphagia and reduced energy expenditure. The observed increase in body weight is of a similar magnitude to murine models of the most extreme forms of monogenic obesity. These data identify TRb in the VMH as a major physiological regulator of food intake and energy homeostasis.
INTRODUCTION
Energy homeostasis is regulated by neurotransmitters and by humoral factors including thyroid hormones, which act within the hypothalamus and systemically to regulate food intake (Coppola et al., 2007; Coll et al., 2007) and energy expenditure (Kim, 2008) . The effects of the active form of thyroid hormone, 3,5,3 0 -L-triiodothyronine (T3), are mediated by two thyroid hormone receptors (TRa and TRb), encoded by Thra and Thrb, respectively (Brent, 2012) . Metabolic phenotypes have been described in mice and humans with TR mutations. Mice with heterozygous dominantnegative mutations of TRa display a variety of metabolic phenotypes ranging from hypermetabolism, hyperphagia, and resistance to diet-induced obesity (Sjö gren et al., 2007) to increased visceral adiposity, hypophagia, and impaired cold-induced adaptive thermogenesis (Liu et al., 2003) . The variation in described phenotypes is likely to be due to the differing actions of individual mutant receptors on wild-type TR function (OrtigaCarvalho et al., 2014) . Humans with heterozygous dominantnegative mutations of TRa (resistance to thyroid hormone a [RTHa]) may be overweight or obese with reduced energy expenditure (Bochukova et al., 2012; Moran et al., 2013 Moran et al., , 2014 . Humans with heterozygous dominant-negative mutations of TRb have RTHb, resulting in high levels of circulating thyroid hormones and thyroid-stimulating hormone (TSH) due to impaired negative feedback of the hypothalamic-pituitary-thyroid axis (Ortiga-Carvalho et al., 2014) . Humans with RTHb may be overweight and hyperphagic (Mitchell et al., 2010) despite features of hyperthyroidism such as tachycardia and raised energy expenditure due to T3 actions in TRa-responsive tissues. These extensive studies demonstrate that thyroid hormone is an essential regulator of food intake and energy expenditure. Despite this, clinical and global gene targeting studies cannot differentiate between the developmental and adult, or systemic and central, effects of thyroid hormones.
The ventromedial hypothalamus (VMH) is a critical region of the brain involved in energy homeostasis. TRb is the predominant TR isoform expressed in the VMH (Cook et al., 1992; Barrett et al., 2007) , and previous studies suggest that thyroid hormones acting in the VMH regulate both food intake (Kong et al., 2004) and energy expenditure (Ló pez et al., 2010) . Thus, we hypothesize that, in the VMH, TRb physiologically regulates food intake and body weight. To investigate this hypothesis directly, we used stereotaxic Cre-lox gene targeting to generate a VMH-specific model of TRb knockdown in adult mice.
RESULTS

Tissue-Specific Knockdown of TRb in the VMH in Adult Mice
We knocked down TRb in the VMH of adult male mice using Cre-mediated excision of a floxed critical exon in the Thrb gene. This approach enabled temporally and spatially controlled reduction of TRb expression specifically in the VMH of adult mice. This model eliminates the developmental consequences and abnormal systemic thyroid hormone levels that occur in global TRb mutant mice (Ortiga-Carvalho et al., 2014) or in hypothyroid and thyrotoxic animals (Ishii et al., 2003; Ló pez et al., 2010) .
The Thrb flox allele contains loxP sites flanking exon 5 of Thrb Figure S1B ). The Thrb flox allele was not excised in either the cerebellum or brainstem, indicating rAAV did not enter the ventricular system following stereotaxic injection ( Figure S1B ). Fluorescence microscopy and in situ hybridization (ISH) both confirmed transgene expression localized to the VMH in both groups of mice (Figures S2A and S2B) . ISH using a probe specific for the floxed exon of Thrb demonstrated reduced expression within the VMH of VMH-TRb À mice compared with controls ( Figures S2C and S2D ).
Selective Knockdown of TRb in the VMH in Adult Mice
Results in Hyperphagia and Obesity VMH-TRb À mice consumed more food and gained more weight than controls ( Figures 1A and 1B) . Weight gain in VMH-TRb In (A)-(C), the results are mean ± SEM; n = 10 for VMH-GFP and 11 for VMH-TRb À . In (E) and (F), the results are median, and whiskers are minimum and maximum; n = 3 for VMH-GFP and 4 for VMH-TRb À ; *p < 0.05; **p < 0.01. Food intake and body weight were analyzed using a generalized estimating equation exchangeable correlation matrix and robust SEs (GEE), body weight data t test. See also Figures S1-S3 and Tables S1 and S2.
Cell Reports 19, 2202-2209, June 13, 2017 2203 mice was three times greater than that of control mice by the end of the study ( Figures 1C and 1D ). Whole hypothalami for RNA-sequencing (RNA-seq) analysis were collected from mice before significant changes in body weight had occurred. This was so that changes in expression are likely to be due to changes in thyroid hormone signaling rather than secondary effects of the increase in body weight and food intake. Differential expression analysis was performed (Table S1 ). Pathway analysis of differentially expressed genes revealed an over-representation of genes involved in dopamine, growth hormone, and leptin signaling pathways, as well as genes that are involved in neuronal activity regulation including long-term potentiation (LTP) and long-term depression (LTD); these results were qualitatively the same when the false discovery rate (FDR) for analysis was set between 0.001 and 0.1 (Table S2 ). Among the genes differentially expressed, Pomc expression was decreased (log Fc À1.38, p = 9.33 3 10 À7 ) ( Figure 1E ), whereas Npy expression was increased (log Fc 0.7, p = 9.42 3 10 À6 ) ( Figure 1F ), whereas that of Thrb was not altered at the level of the whole hypothalamus (Table  S1 ). Expression of steroidogenic factor 1 (Nr5a1), and uncoupling protein-2 (Ucp2), both of which are implicated in hypothalamic control of energy homeostasis (Majdic et al., 2002; Coppola et al., 2007) , were unchanged. The differentially expressed genes were compared to those previously reported to be T3 responsive or directly regulated by T3 in cerebrocortical cells (Tables S1 and S2 and Figure S3 ) (Gil-Ibañ ez et al., 2017) . Of the genes directly regulated by T3 in cerebrocortical cells, we identified 89 ($15%) were also significantly changed in our samples, among which was hairless (Hr). For genes regulated indirectly by T3, we identified 133 that were also changed ($9%). Total, visceral, subcutaneous, and epididymal fat mass were all increased in VMH-TRb À mice compared to controls . In keeping with the increased adiposity, VMH-TRb À mice had a higher plasma leptin concentration than controls ( Figure 2F ). Results are mean ± SEM (n = 3 per group unless stated). **p < 0.01 versus control, t test with Bonferroni correction. See also Figure S4 .
VMH-TRb À Mice Are Systemically Euthyroid
Alterations in circulating thyroid hormones affect food intake and body weight (Pijl et al., 2001 ). Measurement of plasma TSH, thyroxine (T4), and T3 confirmed that both VMH-TRb À and control mice were euthyroid ( Figures S4A-S4C ).
VMH-TRb À Mice Are Insulin Resistant but Do Not Show
Changes in the Expression of Genes Involved in Hypothalamic Glucose Sensing Obese VMH-TRb À mice had high levels of fasting insulin (Figure S4D) , as expected. However, when glucose tolerance and insulin tolerance were tested before the development of obesity in the VMH-TRb À mice, there were no differences between the VMH-TRb À and VMH-GFP mice (Figures S4E and S4F) . RNAseq analysis did not identify changes in expression of hypothalamic glucose-sensing genes.
Obesity in VMH-TRb À Mice Is Not Due to TRb Knockdown in Other Brain Areas
To confirm that the observed weight gain and hyperphagia in VMH-TRb À mice resulted from reduced TRb expression in the VMH and not spread through the ventricular system into other brain regions, rAAV-Cre was injected into both lateral ventricles of Thrb flox/flox mice; a control group of mice were injected with rAAV-GFP. There was no difference in cumulative food intake or body weight gain between these two groups ( Figures S4G  and S4H ).
VMH-TRb À Mice Fail to Mount an Orexigenic Response to Administered T3
In order to validate loss of T3 signaling following TRb inactivation in the VMH, we administered T3 to VMH-TRb À and VMH-GFP mice by subcutaneous injection. Over the 24-hr study period, T3 significantly increased food intake in VMH-GFP mice but VMH-TRb À mice failed to mount an orexigenic response to the administered T3 ( Figure S4I ).
VMH-TRb À Mice Do Not Become Obese When Pair-Fed to the Food Intake of Lean Controls
To investigate whether the hyperphagia contributed to, or was a consequence of, the development of the obese phenotype, VMH-TRb À mice were pair-fed to the food intake of a weightmatched VMH-GFP littermate for 5 weeks. During pair-feeding, there was no difference in cumulative body weight change or food intake ( Figures 3A and 3B ) or locomotor activity between the two groups. After 5 weeks of pair-feeding, ad libitum access to food was restored for 4 weeks. Following restoration of free feeding, VMH-TRb À mice gained significantly more weight and consumed significantly more food than controls ( Figures 3A  and 3C ).
VMH-TRb À Mice Have Reduced Energy Expenditure and
Reduced Locomotor Activity The contribution of changes in energy expenditure to the obese phenotype was investigated. Oxygen consumption (VO 2 ), carbon dioxide production (VCO 2 ), and locomotor activity were all decreased during the dark phase in ad libitum-fed VMH-TRb À mice both before and after the onset of obesity ( Figures 4A-4C ). By contrast, there was no difference in VO 2 , VCO 2 , or locomotor activity during the light phase ( Figures 4A-4C ). The decrease in nocturnal locomotion in VMH-TRb À mice was confirmed by behavioral analysis (Table S3 ). There was no difference in respiratory exchange ratio (RER) ( Figure 4D ) and no difference in brown adipose tissue (BAT) uncoupling protein-1 (Ucp1) expression (Figure 4E) between VMH-TRb À and control mice. In addition, VMHTRb À mice have a normal body temperature ( Figure S4J ).
DISCUSSION
These studies identify hypothalamic TRb as an important physiological regulator of appetite and body weight. Reduced TRb expression in the VMH resulted in marked weight gain, (C) Food intake during the ad libitum feeding period.
Results are mean ± SEM. n = 9; GEE, *p < 0.05; ***p < 0.001.
comparable to severe forms of monogenic obesity (Tecott et al., 1995; Yaswen et al., 1999) . The weight gain was a consequence of increased total body fat, and in particular a marked increase in subcutaneous and visceral white adipose tissue, the latter being an important risk factor for cardiovascular disease and diabetes (Montague and O'Rahilly, 2000) . VMH-TRb À mice ate more than control animals, and pairfeeding studies indicated that hyperphagia contributed directly to the obesity. Thus, VMH-TRb À mice remained lean when food intake was restricted but rapidly became obese when ad libitum feeding was restored. Selective TRb knockdown specifically in the VMH was confirmed by ISH and fluorescence microscopy. Although expression of Thrb was not reduced in the RNA-seq analysis, these samples are derived from whole hypothalami, and therefore the decrease in the level in the VMH is likely masked by the expression of Thrb throughout the rest of the sample. Indeed, the loss of TRb function in the VMH was demonstrated by the failure of the expected orexigenic response to administered T3 in VMH-TRb À mice and further supported by the appropriate changes in genes directly regulated by T3. The possibility of the phenotype arising through virus spread to other CNS areas was excluded by rAAV-Cre injection into the lateral ventricles, which did not result in hyperphagia or obesity.
Previous work in rats has reported the acute orexigenic effect of exogenously administered T3 (Kong et al., 2004) . Here, we show the endogenous effect of thyroid hormone action following selective TRb knockdown. We suggest that our current work describes a local circuit within the VMH that physiologically regulates food intake as distinct from the feeding response to administered pharmacological doses of T3 analogous to the contrasting effects of NPY and PYY.
To investigate the underlying cause of hyperphagia in VMH-TRb À mice, hypothalamic gene expression patterns were determined by RNA-seq. The expression of Pomc and Fto were downregulated in the hypothalamus, whereas Npy was upregulated. POMC and FTO are thought to inhibit food intake, whereas NPY simulates food intake; therefore, these changes in expression may explain in part the phenotype observed. Energy expenditure in VMH-TRb À mice was reduced both before and after the onset of obesity. There was no difference in BAT Ucp1 expression between VMH-TRb À and control mice, suggesting that adaptive thermogenesis was unaffected. It is likely that changes in energy expenditure in VMH-TRb À mice resulted from decreased locomotor activity. The reduced locomotor activity is not a consequence of the obesity because it occurred before differences in body weight. In addition, during pair-feeding studies, the reduction in locomotor activity was lost, Table S3. possibly due to food-seeking behavior. This is likely to explain why body weight gain did not differ between the two groups before the restoration of ad libitum feeding. The energy expenditure and pair-feeding data indicate that both increased food intake and reduced locomotor activity contribute to obesity in VMH-TRb À mice.
In contrast to VMH-TRb À mice, global heterozygous TRb-knockout mice do not have an obese phenotype (OrtigaCarvalho et al., 2014) . This may be explained by the peripheral hyperthyroidism of these mice. In addition, the appetite circuits within the hypothalamus are subject to developmental plasticity and compensatory redundancy (Bouret et al., 2004; Horvath, 2005) . For example, neither global deletion of Agrp and/or Npy nor ablation of arcuate AgRP/NPY neurons in neonatal mice results in a metabolic phenotype (Erickson et al., 1996; Qian et al., 2002; Luquet et al., 2005) , whereas ablation of these neurons in adult mice produces profound hypophagia and starvation (Luquet et al., 2005; Gardiner et al., 2005; Bewick et al., 2005) . Similar developmental compensation may occur in global TRb-knockout mice. Studies using adenovirus-mediated expression of a dominantnegative TR (DN-TR) in the rat VMH have been reported (Ló pez et al., 2010) . Although VMH DN-TR expression did not affect food intake or body weight in euthyroid animals, it prevented weight loss in thyrotoxic rats and resulted in reduced hypothalamic AMP-activated protein kinase (AMPK) expression (Ló pez et al., 2010) . AMPK expression was unchanged in our model. DN-TR interferes with the actions of both TRa and TRb and exerts a marked repressive effect on gene transcription (Ortiga-Carvalho et al., 2014; Ferrara et al., 2012) . By contrast, VMH-TRb À mice have only reduced TRb activity rather than the pathological repression of TR target genes that is present in animals expressing a dominant-negative receptor. This fundamental difference is likely to explain the contrasting phenotypes observed in these two models. In summary, we have shown that hypothalamic TRb is an important physiological regulator of energy homeostasis because TRb knockdown in the VMH results in a phenotype of hyperphagia and severe obesity that is comparable to some of the most extreme forms of monogenic obesity (Tecott et al., 1995; Yaswen et al., 1999) . Our findings provide insights into the central regulation of energy homeostasis by TRb that could be a target for anti-obesity therapies. Figure S1 ). ISH using a probe specific to the excised portion of TRb was performed to confirm reduced TRb expression within the VMH (Smith et al., 2008) .
Measurement of Energy Expenditure
Metabolic parameters were measured by indirect calorimetry using an opencircuit Oxymax system of the Comprehensive Lab Animal Monitoring System (Columbus Instruments) (Gardiner et al., 2010) .
RNA-Seq Analysis
RNA-seq analysis was performed using hypothalamic RNA from VMH-GFP (n = 3) and VMH-TRb À (n = 4) mice using next-generation sequencing (NGS) technologies (Imperial BRC Genomics Laboratory, Imperial College London). For further details, see Supplemental Experimental Procedures.
Statistical Analyses
Cumulative food intake and body weight data were analyzed using generalized estimating equations with exchangeable correlation matrix and robust SEs. Differences between two groups at individual time points were analyzed by unpaired t tests; for multiple comparisons, a Bonferroni correction was applied.
Values from the behavioral study were analyzed using a one-way ANOVA followed by Kruskal-Wallis test. Data from the energy expenditure test were analyzed using a one-way ANOVA followed by a Newman-Keuls test. Plasma thyroid hormones were compared using Mann-Whitney U test. Differences between groups were considered statistically significant at the 95% confidence level (p < 0.05).
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